Back
MoonLake Immunotherapeutics Vs. Novartis AG Industry Stock Comparison
Sell
35
MLTX
MoonLake Immunotherapeutics
Last Price:
$54.50
Seasonality Move:
32.39%
Sell
50
NVS
Novartis AG
Last Price:
$98.40
Seasonality Move:
-2.4%
Sell
35
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
-
The current MoonLake Immunotherapeutics [MLTX] share price is $52.67. The Score for MLTX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
MLTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Novartis AG (NVS)
is a Sell
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVS] share price is $98.35. The Score for NVS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
NVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $52.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight selling pressure.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $98.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MLTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.32 | Buy |
Relative Strength Index (14 RSI): | 50.68 | Buy |
Chaikin Money Flow: | -9093 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.41 - 54.53) | Sell |
Bollinger Bands (100): | (46.75 - 52.99) | Buy |
NVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.31 | Sell |
Relative Strength Index (14 RSI): | 35.77 | Sell |
Chaikin Money Flow: | 253744 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.35 - 104.09) | Sell |
Bollinger Bands (100): | (103.91 - 117.37) | Sell |
MLTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.72 | Sell |
20-day SMA: | 53.24 | Sell |
50-day SMA: | 50.92 | Buy |
200-day SMA: | 46.78 | Buy |
8-day EMA: | 52.7 | Sell |
20-day EMA: | 52.68 | Sell |
50-day EMA: | 51.56 | Buy |
200-day EMA: | 48.46 | Buy |
NVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 97.84 | Buy |
20-day SMA: | 100.62 | Sell |
50-day SMA: | 105.72 | Sell |
200-day SMA: | 106.31 | Sell |
8-day EMA: | 98.28 | Buy |
20-day EMA: | 100.19 | Sell |
50-day EMA: | 104.34 | Sell |
200-day EMA: | 106.38 | Sell |
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.77 per share.
Novartis AG Earnings Growth & NVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.
MoonLake Immunotherapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |